These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9178825)
1. Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine. Ge K; Xu L; Zheng Z; Xu D; Sun L; Liu X Int J Cancer; 1997 May; 71(4):675-9. PubMed ID: 9178825 [TBL] [Abstract][Full Text] [Related]
2. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433 [TBL] [Abstract][Full Text] [Related]
3. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418 [TBL] [Abstract][Full Text] [Related]
4. [Experimental treatment of brain tumor cells using CD suicide gene]. Xu LF; Ge K; Zheng ZC; Sun LY; Liu XY Shi Yan Sheng Wu Xue Bao; 1996 Dec; 29(4):385-93. PubMed ID: 9772683 [TBL] [Abstract][Full Text] [Related]
5. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma. Topf N; Worgall S; Hackett NR; Crystal RG Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575 [TBL] [Abstract][Full Text] [Related]
6. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511 [TBL] [Abstract][Full Text] [Related]
7. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter. Liu J; Zou WG; Lang MF; Luo J; Sun LY; Wang XN; Qian QJ; Liu XY Int J Oncol; 2002 Sep; 21(3):661-6. PubMed ID: 12168115 [TBL] [Abstract][Full Text] [Related]
9. Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit. Yin L; Fu S; Wang X; Nanakorn T; Won J; Deisseroth A Chin Med J (Engl); 2001 Sep; 114(9):972-5. PubMed ID: 11780394 [TBL] [Abstract][Full Text] [Related]
10. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy. Kanyama H; Tomita N; Yamano T; Aihara T; Miyoshi Y; Ohue M; Sekimoto M; Sakita I; Tamaki Y; Kaneda Y; Senter PD; Monden M Cancer Res; 2001 Jan; 61(1):14-8. PubMed ID: 11196152 [TBL] [Abstract][Full Text] [Related]
12. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated tissue-specific cytosine deaminase gene therapy for human hepatocellular carcinoma with different AFP expression levels. Huang X; Zhang W; Wakimoto H; Hamada H; Cao X J Exp Ther Oncol; 2002; 2(2):100-6. PubMed ID: 12415626 [TBL] [Abstract][Full Text] [Related]
16. Provision of positive and negative selections in retroviral vectors containing the cytosine deaminase gene. Shiau AL; Yang HM; Wu P; Wu CL Gene Ther; 1998 Nov; 5(11):1571-4. PubMed ID: 9930312 [TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359 [TBL] [Abstract][Full Text] [Related]
18. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene. Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482 [TBL] [Abstract][Full Text] [Related]
19. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135 [TBL] [Abstract][Full Text] [Related]
20. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model. Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]